Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative
This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk
US probe crashes Indian pharma stocks; Sanofi, Novartis, GSK do not effectively disclose clinical trial data
As India deals with new currency
notes and the US elects Donald Trump as its new President, Phispers